Chapter J
When an offer needs another look
Does the explanation stay clear when you ask a difficult question? A polished page is only the start of the check.
Approval language does not add up
A claim that a compounded medicine has FDA approval is false, as of September 26, 2026.
FDA registration of a facility does not approve its medicine.
Compounded means prepared to order. Ask the service to state the actual product status plainly, without leaning on a badge.
The pharmacy or prescription is missing
Supplying a prescription-only drug without a valid prescription is illegal under federal law, as of September 26, 2026.
FDA’s online-pharmacy checks include a state licence and a pharmacist available for questions.
Before accepting a plan, request the name of the pharmacy. If that question stays unanswered, keep the gap on your comparison sheet.
A treatment menu takes over the assessment
The national medical-board group’s advice from May 2026 says a menu choice alone cannot replace a proper assessment.
Its advice also says patients must be able to put more questions to the person providing their care.
This advice does not itself make the service illegal; the rules that can be enforced come from the patient’s state.
Ask the medical board in your state which rules apply to the service you are considering.
The US agency for consumer protection is the Federal Trade Commission, often called FTC.
The FTC says no government agency approves health ads before publication.
Ask for the research behind a promise, then check whether that research fits the offered treatment.
If sport rules apply to you
As of September 28, 2026, the World Anti-Doping Agency’s current standard names sermorelin as prohibited both during and outside competition.
That agency sets world sport’s drug standard. Ask the body that governs your sport about its rules before deciding on care.